BioBridgeXAll companies

Allosteros Therapeutics Inc.

Biotechnology company · Palo Alto, California, United States

Allosteros Therapeutics Inc. is a biotechnology company headquartered in Palo Alto, California, United States. Its earliest recorded incorporation is in 2009. It has received 7 US government small-business research awards (SBIR/STTR) from health agencies, $1.7 million in total, most recently in 2017. It has reported private securities offerings to the US SEC, most recently $286,000 sold in a notice filed in 2012.

Profile compiled from public records. Is this your company? Request a correction or update

Allosteros Therapeutics at a glance

Typebiotechnology company
HeadquartersPalo Alto, California, United States
Earliest incorporation on record2009
SEC CIK1503753

What does Allosteros Therapeutics do?

US government research funding

7 SBIR/STTR small-business research awards from US health agencies, $1.7 million in total (2011 to 2017). NIH funding came from the National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $286,000 sold (2012).

Frequently asked questions about Allosteros Therapeutics

Where is Allosteros Therapeutics headquartered?

Allosteros Therapeutics Inc. is headquartered in Palo Alto, California, United States.

What does Allosteros Therapeutics do?

Allosteros Therapeutics Inc. is a biotechnology company.

When was Allosteros Therapeutics founded?

The earliest incorporation on record for Allosteros Therapeutics Inc. is in 2009, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences